The oncology drugs companies around the globe have been the hope and pride of millions of people.
Oncology is the study of cancer. It is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist.
Introduction to oncology drugs companies
Cancer survival rates have improved in recent times due to improved prevention efforts to reduce exposure to risk factors, improved screening of several cancers, and improvements in treatment made possible by the oncology drugs companies globally.
There are different branches of medicine that specialize in the diagnosis and treatment of cancer. They include medical oncology (the use of chemotherapy, hormone therapy, and other drugs to treat cancer), radiation oncology (the use of radiation therapy to treat cancer), and surgical oncology (the use of surgery and other procedures to treat cancer).
Top oncology drugs companies
Below are the top oncology drugs companies everyone ought to know;
Address: 100 Abbott Park Road Abbott Park, IL 60064
Phone: (224) 667-6100
Address: 1 N. Waukegan Road, North Chicago, Illinois 60064.
Website: www. abbvie.com
Address: One Amgen Center Drive Thousand Oaks, CA 91320-1799
Phone: +1 805-447-1000
Astellas Pharma Inc
Address: 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan
Address: 1441 Broadway, Ste. # 3159 New York, NY 10018
Phone: (646) 569-5522
Address: 51368 Leverkusen, Germany
Phone: +49 214 30-1
Address: Binger Strasse 173 55216 Ingelheim am Rhein
Phone: +49 – 6132 – 77 0
Fax: +49 – 6132 – 72 0
Bristol-Myers Squibb (BMS)
Address: 430 E. 29th Street, 14th Floor, New York, NY 10016
Report Side Effects or Product Quality Complaints: 1-800-721-5072
Medical Information Contact Center: 1-800-321-1335
Address: 6755 Mississauga Road Suite 600 Mississauga, Ontario L5N 7Y2
Eisai Co Ltd
Address: 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088
Eli Lilly and Co
Address: 893 S Delaware Street, Indianapolis, Indiana 46225, United States
Hoffmann-La Roche Ltd
Address: Konzern Hauptsitz Grenzacherstrasse 124. CH-4070 Basel Schweiz Roche in Switzerland
Phone: +41-61-688 1111
Address: Else-Kröner-Straße 1 61352 Bad Homburg Germany
Phone: +49 6172 686 0
Fax: +49 6172 686 2628
Postal Address: Fresenius Kabi AG 61346 Bad Homburg Germany
ADDRESS: 333 Lakeside Drive Foster City, CA 94404 United States
Phone: +1 650-574-3000
Address: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.
Address: Avinguda de la Generalitat, 152 Parc empresarial Can Sant Joan 08174 Sant Cugat del Vallès, Barcelona SPAIN
Tel: +34 935712200
Fax: +34 938008000
Tel: +800 00027423
Johnson & Johnson
Address: New Brunswick, New Jersey, United States
Zip code: 08933
Address: Frankfurter Strasse 250 Darmstadt, 64293, Germany
Address: Lichtstrasse 35 CH-4056 Basel Switzerland
Phone: +41 61 324 00 00
Fax: +41 61 324 94 42
Tel: +41 61 324 11 11
Fax: +41 61 324 80 01
United States of America
Tel: +1 862 778 21 00
Ono Pharmaceutical Co Ltd
Address: 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka 541-8564, Japan
Otsuka Holdings Co Ltd
Address: 2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan
Address: New York, New York, United States
Phone: (212) 733-2323
Address: 54, rue La Boétie 75008 Paris France
Global headquarters in France: +33 (0)1 53 77 40 00
U.S. headquarters:+1 908 981 5000
Takeda Pharmaceutical Co Ltd
Global Address: 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8668, Japan
Address: 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645
Description of some of the oncology drugs companies in the world
This is one of the top oncology drugs companies in the world. In 2020, AstraZeneca’s oncology business revenue has maintained rapid growth, surpassing US$10 billion for the first time, reaching US$11.455 billion, accounting for 43% of its global revenue.
These oncology products include but are not limited to the third-generation EGFR inhibitor Tagrisso (Osimertinib), PD-L1 monoclonal antibody Imfinzi (Durvalumab), and the PARP inhibitor Lynparza (Olaparib), with a total contribution of 8.146 billion US dollars.
Merck oncology business revenue is tied to Keytruda, of which US$14.38 billion comes from Keytruda’s commercial sales revenue, and the rest is also obtained by bundling Lynparza (Olaparib) and Lenvima (Lenvatinib) with Keytruda.
Pfizer stands among the world’s oncology drugs companies of innovative products and biosimilars in breast cancer, non-small cell lung cancer, gastric cancer, ovarian cancer, renal cell carcinoma, and hematological malignancies.
The two products with the highest revenue in Amgen’s oncology field are Xgeva (Denosumab) and Kyprolis (Carfilzomib), with combined revenue of US$2.964 billion.
Tumor biosimilar drugs Mvasi (bevacizumab-awwb) and Kanjinti (trastuzumab) contributed $1.365 billion in revenue for Amgen.
In 2020, Amgen’s oncology business revenue was US$8.037 billion, accounting for 31.6% of the company’s total revenue, but the growth rate was only 2.1% year-on-year. AbbVie
In 2020, AbbVie’s oncology business revenue was US$6.651 billion, accounting for 14.5% of the company’s total revenue, an increase of 20% year-on-year.
As more and more BTK similar products and BTK C481S inhibitors are coming to market, it will threaten Imbruvica’s market advantage. Looking at AbbVie’s pipeline of oncology products under development, it seems that there is a lack of products with outstanding potential.
Last 2 years, BMS completed the acquisition of Celgene. Although Opdivo (Nivolumab) saw its performance decline for the first time, it has Revlimid (Lenalidomide), Pomalyst (Pomalidomide), Sprycel (Dasatinib), Yervoy (Ipilimumab), Abraxane (Protein-bound paclitaxel) and Empliciti (Elotuzumab) and other oncology drug product portfolio, BMS has become the global oncology business leader.
In 2020, oncology drug sales revenue reached US$28.419 billion, accounting for 66.84% of the company’s overall revenue, an increase of 118.4% year-on-year.
Revlimid has become the new top brand of BMS, with annual sales reaching 12.106 billion US dollars. Together with Opdivo’s 6.992 billion US dollars, the two contributed approximately 19.1 billion US dollars to BMS.
This oncology drug company was developed by Sol J. Barer in 1986. It’s a global biopharmaceutical company with headquarters in Summit, New Jersey. Its subsidiaries include Celgene Co, Signal Pharmaceutical, Celgene Srl, Celgene Sarl, and others.
Celgene is a pharmaceutical company that makes cancer and immunology drugs. The company is one of the largest members, in terms of network, of the oncology pharma companies
Conclusion on the drugs oncology companies
The list of these companies is in no order of ranking, every company listed is reputable and most are multinational pharmaceutical companies having branches in more than 20 countries.
We alphabetically arranged these cancer drug-producing companies for easy access that’s why the official websites and contact addresses of these companies are provided in each of the companies.
We are open to suggestions and recommendations. You can air your view in the comment section below.